They say there’s no such thing as a free lunch, and for doctors fed by drug companies, the old adage might be true, a JAMA study found.

In the pharma world, waiting room marketing is often overlooked for its sexier DTC cousin. But point-of-care advertising now accounts for about 10% of pharma’s…

Eli Lilly has been racking up new Trulicity data to build a broader case for the weekly GLP-1 med, and a new study now shows that adding it to Lantus beat…

Millennial doctors are conflicted about pharma. They believe drugmakers give them helpful info, but almost two-thirds don’t trust it. Half call DTC ads…

CHICAGO--The ASCO annual meeting is the biopharma version of Cannes or Sundance: Non-stop premieres, news conferences, sideline interviews and more. Track this…

Coming soon: Artificial intelligence-powered ads that can chat. Think IBM’s Watson engine, with ads powered to answer “conversational queries like ‘is this…

Payers and healthcare systems seeking reprieve from growing cancer costs had better buckle in. According to a new report, a record number of debut meds will…

ASCO stepped up the drug-cost debate last year when it proposed a tool to help physicians and patients compare meds. Now, the group has tweaked that tool, and…

Data and Analytics